Friend, Are you living with obesity and considering starting a GLP-1 medication for weight management?
Omada Health, with support from the Obesity Action Coalition (OAC), is seeking participants for a new 6-month virtual care clinical research study. The study is designed to better understand real-world experiences and changes in weight, health and body composition among people starting GLP-1 treatment through a virtual care program.
As part of this study, Omada Health will provide GLP‑1 telehealth prescribing services along with lifestyle and behavioral support designed to help you build healthy habits, maintain strength and work toward your health goals.
What you’ll get if you qualify and participate in the study: - 7 months of reimbursable GLP-1 medications (during the 6-month study period and the following month after the study has completed)
- Access to a virtual GLP‑1 lifestyle coaching program at no program cost to you
- A body composition (BIA) scale connected via an app
- An at‑home exercise kit (such as resistance bands and related tools)
- Regular digital support to help with weight, activity, nutrition, and medication use
- Up to $80 for completing three study assessments
Interested in learning more? Answer a few quick questions to see whether you may be eligible. | |
Please note this study is being conducted by an independent company. The Obesity Action Coalition is sharing this opportunity for informational purposes only and is not involved in the study, medical care or participant selection. | |
